当前位置:首页 - 行情中心 - 海创药业-U(688302) - 财务分析 - 现金流量表

海创药业-U

(688302)

  

流通市值:54.09亿  总市值:54.09亿
流通股本:9901.56万   总股本:9901.56万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金19,840,149.5713,016,2905,000414,350
  收到其他与经营活动有关的现金34,656,225.6225,983,333.784,894,824.8720,605,074.43
  经营活动现金流入小计54,496,375.1938,999,623.784,899,824.8721,019,424.43
  购买商品、接受劳务支付的现金3,111,340.432,152,824.82547,833.11292,186.69
  支付给职工以及为职工支付的现金57,199,710.1837,333,856.0417,131,967.1570,143,751.64
  支付的各项税费588,066.12507,824.6174,301.97438,447.2
  支付其他与经营活动有关的现金73,306,230.3646,433,160.1822,400,628.7137,228,097.71
  经营活动现金流出小计134,205,347.0986,427,665.6540,154,730.93208,102,483.24
  经营活动产生的现金流量净额-79,708,971.9-47,428,041.87-35,254,906.06-187,083,058.81
二、投资活动产生的现金流量:
  收回投资收到的现金1,870,050,0001,300,050,000350,050,0003,945,000,000
  取得投资收益收到的现金5,940,964.774,064,380.13938,215.5314,037,537.25
  处置固定资产、无形资产和其他长期资产收回的现金净额147.38--2,175.57
  收到的其他与投资活动有关的现金41,397,341.6334,740,430.6622,885,515.86-
  投资活动现金流入小计1,917,388,453.781,338,854,810.79373,873,731.393,959,039,712.82
  购建固定资产、无形资产和其他长期资产支付的现金57,314,600.6741,503,612.826,661,483.3189,549,635.6
  投资支付的现金2,070,050,0001,310,050,000720,050,0003,865,000,000
  支付其他与投资活动有关的现金8,698,614.48,698,614.46,656,910.9734,740,430.66
  投资活动现金流出小计2,136,063,215.071,360,252,227.2753,368,394.283,989,290,066.26
  投资活动产生的现金流量净额-218,674,761.29-21,397,416.41-379,494,662.89-30,250,353.44
三、筹资活动产生的现金流量:
  取得借款收到的现金100,000,000100,000,000--
  筹资活动现金流入平衡项目00--
  筹资活动现金流入小计100,000,000100,000,000--
  分配股利、利润或偿付利息支付的现金592,527.78---
  支付其他与筹资活动有关的现金2,763,637.471,842,424.981,220,156.494,056,317
  筹资活动现金流出小计3,356,165.251,842,424.981,220,156.494,056,317
  筹资活动产生的现金流量净额96,643,834.7598,157,575.02-1,220,156.49-4,056,317
四、汇率变动对现金及现金等价物的影响-1,084,227.63-339,461.45-135,438.331,427,097.07
五、现金及现金等价物净增加额-202,824,126.0728,992,655.29-416,105,163.77-219,962,632.18
  加:期初现金及现金等价物余额593,226,056.49593,226,056.49593,226,056.49813,188,688.67
  期末现金及现金等价物余额390,401,930.42622,218,711.78177,120,892.72593,226,056.49
补充资料:
  净利润--61,853,200.96--199,495,736.1
  固定资产和投资性房地产折旧-1,392,215.42-2,070,963.01
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-1,392,215.42-2,070,963.01
  长期待摊费用摊销---41,232.53
  处置固定资产、无形资产和其他长期资产的损失---1,063.8
  公允价值变动损失--2,054,220.43--3,962,834.76
  财务费用--956,367.24--3,983,228.64
  投资损失--1,843,351.3--9,144,656.32
  存货的减少--1,048,631.03-1,019.34
  经营性应收项目的减少--6,598,876.25-5,918,932.58
  经营性应付项目的增加-16,164,333.26--7,542,197.07
  其他-7,029,599.25-24,789,767.04
  现金的期末余额-622,218,711.78-593,226,056.49
  减:现金的期初余额-593,226,056.49-813,188,688.67
  现金及现金等价物的净增加额-28,992,655.29--219,962,632.18
公告日期2025-10-312025-08-142025-04-262025-04-19
审计意见(境内)标准无保留意见
TOP↑